These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26896745)

  • 1. Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma.
    De Voogd FA; Gearry RB; Mulder CJ; Day AS
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1386-92. PubMed ID: 26896745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin.
    Byrne FR; Morony S; Warmington K; Geng Z; Brown HL; Flores SA; Fiorino M; Yin SL; Hill D; Porkess V; Duryea D; Pretorius JK; Adamu S; Manoukian R; Danilenko DM; Sarosi I; Lacey DL; Kostenuik PJ; Senaldi G
    Gut; 2005 Jan; 54(1):78-86. PubMed ID: 15591508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of bone metastasis: the role of osteoprotegerin and of the host-tissue microenvironment-related survival factors.
    Fili S; Karalaki M; Schaller B
    Cancer Lett; 2009 Sep; 283(1):10-9. PubMed ID: 19201081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of osteoprotegerin expression correlates with bone invasion and predicts poor clinical outcome in oral cancer.
    Russmueller G; Moser D; Würger T; Wrba F; Christopoulos P; Kostakis G; Seemann R; Stadler V; Wimmer G; Kornek G; Psyrri A; Filipits M; Perisanidis C
    Oral Oncol; 2015 Mar; 51(3):247-53. PubMed ID: 25532817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin: multiple partners for multiple functions.
    Baud'huin M; Duplomb L; Teletchea S; Lamoureux F; Ruiz-Velasco C; Maillasson M; Redini F; Heymann MF; Heymann D
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):401-9. PubMed ID: 23827649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets.
    van Herk EH; Te Velde AA
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1393-404. PubMed ID: 26990130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis.
    Goswami S; Sharma-Walia N
    BMC Cancer; 2015 Nov; 15():935. PubMed ID: 26608463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in patients with neuroblastoma.
    Granchi D; Garaventa A; Amato I; Paolucci P; Baldini N
    Int J Cancer; 2006 Jul; 119(1):146-51. PubMed ID: 16450378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin in breast cancer: beyond bone remodeling.
    Weichhaus M; Chung ST; Connelly L
    Mol Cancer; 2015 Jun; 14():117. PubMed ID: 26054853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of osteoprotegerin (OPG) in cancer.
    Holen I; Shipman CM
    Clin Sci (Lond); 2006 Mar; 110(3):279-91. PubMed ID: 16464170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the kidney.
    Candido R
    Curr Opin Nephrol Hypertens; 2014 Jan; 23(1):69-74. PubMed ID: 24247823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.
    Hofbauer LC; Khosla S; Dunstan CR; Lacey DL; Boyle WJ; Riggs BL
    J Bone Miner Res; 2000 Jan; 15(1):2-12. PubMed ID: 10646108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological roles of osteoprotegerin (OPG).
    Reid P; Holen I
    Eur J Cell Biol; 2009 Jan; 88(1):1-17. PubMed ID: 18707795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells.
    Kobayashi-Sakamoto M; Isogai E; Holen I
    Eur J Haematol; 2010 Jul; 85(1):26-35. PubMed ID: 20331738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
    Van Poznak C; Cross SS; Saggese M; Hudis C; Panageas KS; Norton L; Coleman RE; Holen I
    J Clin Pathol; 2006 Jan; 59(1):56-63. PubMed ID: 16394281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoclastogenesis Inhibitory Factor (OCIF) /Osteoprotegerin (OPG) as a new therapeutic agent for osteoporosis].
    Mochizuki S; Kiyokawa A; Nagayama Y
    Clin Calcium; 2005 Jan; 15(1):35-42. PubMed ID: 15632471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin is expressed in colon carcinoma cells.
    Pettersen I; Bakkelund W; Smedsrød B; Sveinbjørnsson B
    Anticancer Res; 2005; 25(6B):3809-16. PubMed ID: 16309167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune function of the decoy receptor osteoprotegerin.
    Bengtsson AK; Ryan EJ
    Crit Rev Immunol; 2002; 22(3):201-15. PubMed ID: 12498383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells.
    Kanzaki H; Ohtaki A; Merchant FK; Greene MI; Murali R
    Exp Mol Pathol; 2013 Apr; 94(2):372-9. PubMed ID: 23219833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.